Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLIN – Colchicine as adjunct therapy in acute myocardial infarction
2014-002739-32Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of colchicine in myocardial infarction (MI) (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Change in C-reactive protein (CRP) over first 5 days. Started Jun 2015; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2014-002739-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002739-32.